close

Themis Medicare Ltd

Know More
NSEBSE

1808.4045.35 (2.57%)

12:00 AM,29th Sep 2023

1809.8549.80 (2.83%)

12:00 AM,29th Sep 2023

BSE : 530199

NSE : THEMISMED

Sector : Health care

ISIN Code : INE083B01016

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Sep 29 2023 | 12:00 AM IST

Market Cap (₹ Cr)

1663

Turnover (₹ Cr)

0.25

Volume (Shares)

13892

Face Value

10

52-WK High

1834.00

52-WK High Date

29 Sep 2023

52-WK Low

877.65

52-WK Low Date

18 Nov 2022

All Time High

1834.00

All Time High Date

29 Sep 2023

All Time Low

40.00

All Time Low Date

04 Sep 2013

Themis Medicare Ltd

Incorporated in 1969 Themis Medicare Ltd. formerly known as Themis Chemicals (TCL) was originally promoted by Chemosyn and Medimpex but was taken over by a group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics which was merged with Artemis Pharmaceuticals in April 93.In Mar.'95 the company came out with a public issue equity shares (premium : Rs 110) to finance the expansion-cum-modernisation of its synthetic bulk drug plant at Vapi the setting up of a formulation unit at Lilora Baroda as backward integration and to augment long-term working capital.Total cost of the project was estimated at Rs 17.64 cr. TCL manufactures and sells synthetic bulk drugs and formulations. It operates in the therapeutic segments of anti-tuberculosis cerebroactivators bronchodilators anti-asthmatic anaesthetic and other segments.Anti-tuberculosis bulk drugs and formulations account for 60% of its turnover and the company is rated fourth in terms of turnover in this segment. TCL has also started manufacturing and exporting fumagillin an anti-bacterial drug for veterinary use for which it has a confirmed buy-back arrangement with Chinoin Hungary.The company with the help of M/s PharmogradMoscow a manufacturing unit is planning to market its Anti-T.B.formulation products through the collborators throughout the Russian Federation for tradetenders and govt.supplies.

Themis Medicare Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

1663

EPS - TTM (₹) [S]

48.05

P/E Ratio (X) [S]

6.71

Face Value (₹) 10
Latest Dividend (%)50.00
Latest Dividend Date 01 Sep 2023
Dividend Yield (%) 0.28
Book Value Share (₹) [S]269.54
P/B Ratio (₹) [S]6.71
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)
Motilal Oswal S&P BSE Healthcare ETF 0.00 31 0.06

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

1741.95

1834.00

Week Low/High

1688.15

1834.00

Month Low/High

1560.00

1834.00

Year Low/High

877.65

1834.00

All time Low/High

12.00

1834.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week4.99%4.95%-0.27-0.18%
1 Month12.99%13.23%1.161.53%
3 Month31.08%31.68%2.993.51%
6 Month63.43%62.77%14.2615.85%
1 Year80.61%80.11%16.7016.77%
3 Year439.10%439.18%73.3574.99%

Financials

Graph
Table

Bulk/ Block

ALL
NSE
BSE
ALL
BUY
SELL
DateClient NameExchangeTransactionQuantityPrice
02-06-2021TEJAS TRADEFIN LLPNSEBUY72009735.76
12-03-2013ANUJ ANANTRAI SHETHBSEBUY11250060.25
12-03-2013GAGANDEEP CREDIT CAPITAL PRIVATE LIMITEDBSESELL11250060.25
26-03-2010KISHORCHAND RATULSIDAS LAKDAWALABSESELL235712181.50
26-03-2010THEMIS DISTRIBUTORS PVT. LTD.BSEBUY234612181.50
04-03-2010DINESH SHANTILAL PATELBSEBUY241712175.00
04-03-2010KISHOR CHANDRA TULSIDAS LAKDAWALABSESELL89976175.00
04-03-2010RANJANBEN KISHORE CHANDRA LAKDAWALABSESELL133536175.00

Peer Group Comparison

NamePrice(In Rs)Chg(%)Mkt Cap(Rs Cr)Sales(Rs Cr)Profit(Rs Cr)EPS(Rs)P/E(x)

Shareholding Pattern

Jun 2023
Archive
CategoryShare(%)
Promoter67.16
Financial Institutions Banks0.01
Foreign Institutional Investors0.04
Insurance Companies0.00
Mutual Funds Uti0.00
Other Institutional Investors0.00
Indian Public22.64
Others Non Institutional Investors10.15
Custodians0.00

Corporate Action

Announcement DatePurposeFromToRemarks
Data Not Found

Price History

Search for Price History

DateOpenHighLowCloseSharesTrades
Data Not Found

Load more

Company Info

Company Information

Non-Exec & Non-Independent Dir : Rajneesh Anand

Independent Non Exe. Director : VIJAY GOPI KISHAN AGARWAL

Independent Non Exe. Director : Hari Subramaniam

Non Executive Director : Reena S Patel

ED / MD / CEO / Promoter : Sachin D Patel

Chairman & Independent Directo : Dinesh S Patel

Independent Non Exe. Director : Manjul Sandhu

Independent Non Exe. Director : Bhaskar Vemban Iyer

Additional Director : Shishir Dalal

Alternate Director : Reena S Patel

Registered Office: Plot No 69 A GIDC Indl Estate, Vapi,Valsad,Gujarat-396195 Ph: 91-260-2421675

Email:themis@themismedicare.com

URL:http://www.themismedicare.com